Dear Jacob,

you cannot kill a virus. It is not alive, but a complex chemical
compound that interferes with the chemistry of the host. So why don't
you work on the part of your conept over the week-end and present the
concept?

Cheers,
Tim


On Fri, 19 Feb 2021 12:55:32 -0500 Jacob Keller
<[email protected]> wrote:

> I don't think seeing the big picture resolves, or even addresses, the
> question of possibly using a live vaccine. Some big-picture
> considerations favor each side.
> 
> The concern of mutation is a grave one, and an unknown. I would point
> out, however, that the same considerations apply to the wild virus
> currently scourging the planet (well, and every other virus currently
> slinking around the biome). The distinction would be, I guess, that
> we would be actively contributing in some way. On the other hand,
> maybe being passive is like not throwing a rope to a drowning man?
> 
> Maybe having a "v-day" would address this: introduce the
> virus-vaccine at well-chosen locations, aka super-spreader events,
> which, like well-placed demolition dynamite, would cause a "flash
> pan-infection." Funnily, this would require all of the pandemic rules
> to be turned on their heads! Presumably this generates herd immunity
> within a couple of weeks, as well as its fair share of adverse
> reactions and deaths. As a safety measure, have two orthogonal
> chemical kill switches based on plentiful inexpensive well-tolerated
> compounds, say a vitamin or pesticide (yes, pesticide, that stuff
> that's always sprayed all over your food). Use those to quench the
> vaccine before mutation, say 6-8 wks. Then, back to normal life, and
> start honing similar tools for coming pandemics, a "holohomoimmune
> system."
> 
> Here's a question to the informed-consent hawks: would exposing
> everybody to the virus while providing two compounds to block
> completely the effects be considered a valid opt-in/out? Or what if
> the default was switched, such that both compounds were required for
> infection, and therefore one had to actively opt in?
> 
> I don't know--it seems that many of the objections to the idea are
> based on the bioethical concept "first do no harm," but that
> principle is not necessarily adopted in all cases.
> 
> One of the best things I learned in med school:
> 
> Medicine is, fundamentally, "uncertainty management:"
> 
> there are almost never any certainties in medicine, and one has to
> use a Bayesian framework and a few bioethical principles to figure
> out what to do next.
> 
> Anyway, rest assured, I have not yet ordered the primers for creating
> such a virus-vaccine...
> 
> All the best, and have a good weekend everyone,
> 
> Jacob
> 
> 
> 
> On Fri, Feb 19, 2021 at 5:54 AM Robbie Joosten
> <[email protected]> wrote:
> 
> > Hi Tim,
> >
> > Very good points. The big picture is hard to grasp and we end up
> > taking political choices rather than anything else. I'm very glad
> > that we can outsource these choices to others every four year here.
> >
> > Lockdowns may save lives in the here and now, but the global
> > economic damage makes life for others much harder to a point that
> > it may actually kill them. Economic decline in the First World may
> > be something with which that we can deal but, like viruses, it
> > blows over to other parts of the world where economic growth is the
> > real life saver. Does the prolonging of a reasonably measurable
> > number well-lived lives in the West outweigh the extinguishing of a
> > hard-to-assess number of much younger lives in the rest of the
> > world? I'm glad I don't have to make that call.
> >
> > Cheers,
> > Robbie
> >  
> > > -----Original Message-----
> > > From: CCP4 bulletin board <[email protected]> On Behalf Of Tim
> > > Gruene
> > > Sent: Friday, February 19, 2021 09:33
> > > To: [email protected]
> > > Subject: Re: [ccp4bb] Contagious, Self-Distributing "Vaccines?"
> > >
> > > Hi Jessica,
> > >
> > > one comment: death cannot be prevented. It is a certainty as soon
> > > as you are born (well, 9 months before).
> > >
> > > While this seems an obvious subtlety, many of the current
> > > measures seems to be influenced by the (probably unconscious)
> > > belief one can defeat  
> > death.  
> > > We can only reduce the risk to die at a certain moment and of a
> > > certain cause.
> > >
> > > The example of rabbits in Australia also illustrates how simple
> > > minded humans generally are: we focus on one thing, but usually
> > > fail to take a  
> > larger  
> > > picture into account.
> > >
> > > Cheers,
> > > Tim
> > >
> > >
> > >
> > > On Thu, 18 Feb 2021 08:16:59 -0800 Jessica Bruhn
> > > <[email protected]> wrote:
> > >  
> > > > Hello,
> > > >
> > > > There have been some really excellent points raised by others
> > > > (informed consent, feasibility, etc), but I would like to share
> > > > a story about another time humans tried to release a virus on a
> > > > wild population in order to further an arguably noble goal:
> > > >
> > > > In the 1850s European rabbits were introduced in Australia for
> > > > sport hunting. They quickly did what bunnies do and started to
> > > > become a real problem. In the 1950s, scientists decided to
> > > > introduce myxoma virus to Australia, which is 90-99% fatal for
> > > > European rabbits, but less lethal for the native rabbits. They
> > > > intentionally released this virus and in the first year the
> > > > mortality rate was 99.8% for the European rabbits. Yay,
> > > > right??? Unfortunately, in the subsequent year the mortality
> > > > rate fell to 25% and steadily continued to fall until it was
> > > > lower than the reproductive rate of the European rabbits. The
> > > > host-virus interaction played itself out: less-virulent viruses
> > > > arose and resistant rabbits were selected for.
> > > >
> > > > To me it seems unwise to assume a replication competent virus
> > > > (engineered or not) would refrain from mutating and adapting
> > > > upon release, especially over the time course that would be
> > > > required to infect all 7 billion+ humans on this planet. To me,
> > > > I feel our options are (1) reach herd immunity through natural
> > > > infection and accept the preventable deaths of many millions of
> > > > people or (2) continue with non-pharmaceutical interventions
> > > > (mask wearing, distancing, etc) until we can vaccinate enough
> > > > people to reach herd immunity and hopefully by that time we
> > > > have robust testing and treatment options available for those
> > > > who continue to fall ill after we reach herd immunity. We as
> > > > humans did something amazing by producing multiple safe and
> > > > effective vaccines in less than one year, and I would like us
> > > > to continue trying to save as many lives as possible by
> > > > employing these vaccines as widely as possible.
> > > >
> > > > Anyways, take care. I know the pandemic is hard on all of us.
> > > >
> > > > Best regards,
> > > > Jessica
> > > >
> > > > On Thu, Feb 18, 2021 at 6:15 AM Patrick Shaw Stewart
> > > > <[email protected]> wrote:
> > > >  
> > > > > I agree with those who say that A and B are usually
> > > > > incompatible.
> > > > >
> > > > > If we're like
> > > > > chickens-in-a-barn-that-have-been-infected-with-bird-flu, the
> > > > > virus very rapidly becomes more virulent (hospital and
> > > > > care-home infections?).  It's hard for a virus to infect your
> > > > > nose and throat quickly, and then stop.
> > > > >
> > > > > In the medium term the herd will build up some immunity and
> > > > > then we'll become more like wandering albatrosses: the virus
> > > > > has to keep us on the move if it's going to get itself near
> > > > > another susceptible host.
> > > > >
> > > > > IMO the way a *respiratory *virus tries to "have its cake and
> > > > > eat it" - that is, get as much of both A and B as possible -
> > > > > is to develop thermal sensitivity.  I.e. infect nose and
> > > > > throat but keep out of lungs and brain :
> > > > >
> > > > > https://www.preprints.org/manuscript/202101.0389/v1
> > > > >
> > > > >
> > > > >
> > > > > Thanks, Patrick
> > > > >
> > > > >
> > > > > On Wed, Feb 17, 2021 at 9:46 PM Edwin Pozharski
> > > > > <[email protected]> wrote:
> > > > >  
> > > > >> I guess for such vehicle to be "extremely contagious" (or
> > > > >> contagious at all for that matter) it should be capable of
> > > > >> rapidly multiplying inside the host, so that it outruns
> > > > >> immune system mediated destruction for at least some time in
> > > > >> order to be present in high enough concentration to
> > > > >> effectively spread via aerosols. Given the range of
> > > > >> immunodeficiencies present in any population, you are
> > > > >> essentially guaranteed to kill at least some people whose
> > > > >> immune system will not be able to cope with rapidly
> > > > >> multiplying virus.  You can theoretically fine tune the
> > > > >> lethality of such virus to make sure that number of people
> > > > >> you thus murder will be less than those that die either in
> > > > >> no vaccine or traditional vaccination scenario, but that
> > > > >> would be ethical equivalent of that modern crypto fascist
> > > > >> suggestion that we just have to take it easy until herd
> > > > >> immunity is established, even though few million
> > > > >> grandparents will die in the process while the rest of us
> > > > >> enjoy indoor dining.
> > > > >>
> > > > >>
> > > > >>
> > > > >> On Wed, Feb 17, 2021 at 12:33 PM Jacob Keller
> > > > >> <[email protected]> wrote:
> > > > >>  
> > > > >>> It would seem to me that it should be possible to generate
> > > > >>> versions of the Covid virus that would:
> > > > >>>
> > > > >>> A. be extremely contagious and yet B. be clinically benign,
> > > > >>> and C. confer immunity to the original covid virus.
> > > > >>>
> > > > >>> If, then, this virus could be released, with appropriate
> > > > >>> "kill switch" safeguards built in, would this not solve the
> > > > >>> world's pandemic problems? Is there any reason,
> > > > >>> practically, why this approach would not be feasible?
> > > > >>>
> > > > >>> Maybe we don't really know enough to manipulate A, B, C yet?
> > > > >>>
> > > > >>> Or maybe it's too scary for primetime...nightmare
> > > > >>> bio-warfare apocalypse?
> > > > >>>
> > > > >>> Has this sort of thing been done, or does it have a name?
> > > > >>>
> > > > >>> Jacob
> > > > >>> --
> > > > >>>
> > > > >>> +++++++++++++++++++++++++++++++++++++++++++++++++
> > > > >>>
> > > > >>> Jacob Pearson Keller
> > > > >>>
> > > > >>> Assistant Professor
> > > > >>>
> > > > >>> Department of Pharmacology and Molecular Therapeutics
> > > > >>>
> > > > >>> Uniformed Services University
> > > > >>>
> > > > >>> 4301 Jones Bridge Road
> > > > >>>
> > > > >>> Bethesda MD 20814
> > > > >>>
> > > > >>> [email protected]; [email protected]
> > > > >>>
> > > > >>> Cell: (301)592-7004
> > > > >>>
> > > > >>> +++++++++++++++++++++++++++++++++++++++++++++++++
> > > > >>>
> > > > >>> ------------------------------
> > > > >>>
> > > > >>> To unsubscribe from the CCP4BB list, click the following
> > > > >>> link: https://www.jiscmail.ac.uk/cgi-bin/WA-  
> > > JISC.exe?SUBED1=CCP4BB&A=1  
> > > > >>>  
> > > > >>
> > > > >> ------------------------------
> > > > >>
> > > > >> To unsubscribe from the CCP4BB list, click the following
> > > > >> link:
> > > > >> https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1 
> > > > >
> > > > >
> > > > > --
> > > > >  [email protected]    Douglas Instruments Ltd.
> > > > >  Douglas House, East Garston, Hungerford, Berkshire, RG17
> > > > > 7HD, UK Directors: Patrick Shaw Stewart, Peter Baldock,
> > > > > Stefan Kolek
> > > > >
> > > > >  http://www.douglas.co.uk
> > > > >  Tel: 44 (0) 148-864-9090    US toll-free 1-877-225-2034
> > > > >  Regd. England 2177994, VAT Reg. GB 480 7371 36
> > > > >
> > > > > ------------------------------
> > > > >
> > > > > To unsubscribe from the CCP4BB list, click the following link:
> > > > > https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1
> > > > >  
> > > >
> > > >  
> > > ###############################################################
> > > #######  
> > > > ##
> > > >
> > > > To unsubscribe from the CCP4BB list, click the following link:
> > > > https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1
> > > >
> > > > This message was issued to members of
> > > > www.jiscmail.ac.uk/CCP4BB, a mailing list hosted by
> > > > www.jiscmail.ac.uk, terms & conditions are available at
> > > > https://www.jiscmail.ac.uk/policyandsecurity/  
> > >
> > >
> > >
> > > --
> > > --
> > > Tim Gruene
> > > Head of the Centre for X-ray Structure Analysis Faculty of
> > > Chemistry University of Vienna
> > >
> > > Phone: +43-1-4277-70202
> > >
> > > GPG Key ID = A46BEE1A
> > >
> > > ###############################################################
> > > #########
> > >
> > > To unsubscribe from the CCP4BB list, click the following link:
> > > https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1
> > >
> > > This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a
> > > mailing list hosted by www.jiscmail.ac.uk, terms & conditions are
> > >  
> > available at  
> > > https://www.jiscmail.ac.uk/policyandsecurity/  
> >
> > ########################################################################
> >
> > To unsubscribe from the CCP4BB list, click the following link:
> > https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1
> >
> > This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a
> > mailing list hosted by www.jiscmail.ac.uk, terms & conditions are
> > available at https://www.jiscmail.ac.uk/policyandsecurity/
> >  
> 
> 



-- 
--
Tim Gruene
Head of the Centre for X-ray Structure Analysis
Faculty of Chemistry
University of Vienna

Phone: +43-1-4277-70202

GPG Key ID = A46BEE1A

########################################################################

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1

This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a mailing list 
hosted by www.jiscmail.ac.uk, terms & conditions are available at 
https://www.jiscmail.ac.uk/policyandsecurity/

Attachment: pgpjzW6WHXIer.pgp
Description: OpenPGP digital signature

Reply via email to